Evidence map›Paper›PMID 23540748›Full record

ArticleSeminars in oncology2013

Asymptomatic cardiac toxicity in long-term cancer survivors: defining the population and recommendations for surveillance.

Joseph R Carver, Dava Szalda, Bonnie Ky

Open access · greenAbstract read
In one paragraph

Article in Seminars in oncology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Article
  3. Current State of Pediatric Cardio-Oncology: A Review.Children (Basel, Switzerland) · 2022
    Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Air Pollution across the Cancer Continuum: Extending Our Understanding of the Relationship between Environmental Exposures and Cancer.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2020
    Article
  9. Article
  10. Article
  11. Review
  12. Preventive Cardio-Oncology: The Time Has Come.Frontiers in cardiovascular medicine · 2019
    Article
  13. SEOM clinical guidelines on cardiovascular toxicity (2018).Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2019
    Article
  14. Review
  15. Article
  16. Review
  17. Observational
  18. Breast cancer therapy-associated cardiovascular disease.Nature reviews. Clinical oncology · 2016
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Joseph R CarverCardio-oncology in the Division of Cardiology, University of Pennsylvania, Philadelphia, PA 19104, USA. jrc@mail.med.upenn.edu
Dava Szalda
Bonnie Ky
University of Pennsylvania · USChildren's Hospital of Philadelphia · US

Funding

The Role of Neuregulin in Human Cardiac Remodeling and Heart FailureK23HL095661 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI KY, BONNIE · 2010 to 2014
$704k
NHLBI NIH HHS K23 HL095661
6 · The paper itself

Abstract

Advances in the treatment of pediatric and adult cancer have reduced the mortality rates from these disorders and have led to an ever-increasing population of long-term survivors. Chemotherapy and radiotherapy may cause premature cardiac disease that may be asymptomatic or symptomatic. All patients exposed to chemotherapy with cardiotoxic potential or chest radiotherapy have stage A heart failure and the goal of surveillance and treatment is to prevent progression to stages B-D. Screening strategies, including the use of biomarkers, echocardiography, and expert opinion surveillance and treatment recommendations, are presented.

Indexed as

SurvivorsAntineoplastic AgentsAsymptomatic DiseasesCardiovascular DiseasesEpidemiological MonitoringHumansMass ScreeningNeoplasmsPopulationPractice Guidelines as TopicRadiation InjuriesAntineoplastic Agents

Identifiers

PMID23540748
PMCPMC3686285
OpenAlexW1968130898

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.